
|Videos|March 30, 2022
Risk Models and Prognostic Factors
Author(s)Robert S. Alter, MD
Robert Alter, MD comments on the use of prognostic models for determining risk status and informing treatment options in patients with RCC.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts Topical Gel sNDA for Superficial Basal Cell Carcinoma
2
How KTX-1001 May Address Gap in Unique Multiple Myeloma Biologic Subtype
3
Phase 2b Prostate Cancer Study Receives FDA Clearance in High-Risk Groups
4
Joining Commercialization and Innovation to Bring New Cancer Therapies
5















































